NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/25/2026
Back to search
Official data from USPTO
MABXIENCE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
MABXIENCE
ST13
US500000079975374Class
5, 42
Filing
79975374
Registration
5472348
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
48
Latest update
06/25/2026
Classification
Registered
Trademark type
Word
Nice classes
5, 42
Filing date
07/28/2016
Registration date
05/22/2018
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/06/2024
Last transaction
06/25/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
E-28050 MADRID (MADRID), ES
Examiner
FALK, JONATHAN ROBERT
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
MABXIENCE RESEARCH, S.L.
Representatives
VIVIAN ORTIZ PONCE MARCAS ESTADOS UNIDOS
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of ophthalmic diseases and disordersdermatological diseases and disorderspharmaceutical preparations for use in treating digestive diseases and disordersgynecological diseases and disordershormonal diseases and disordersblood disorderscancercardiovascular diseasesvascular diseasesgastrointestinal diseasesgenitourinary diseasesgenitourinary disordersimmunologic diseasesinfectious diseasesinflammatory diseasesmetabolic diseases and disordersneurological diseasespsychiatric diseasescentral nervous system; pharmaceutical preparations for the treatment of diseases of the musculoskeletal systemdiseases of the respiratory systemcirculatory systemcirculatory diseasesviral diseasesglaucomadental and oral diseasesheadachesmigraineobesityhepatic treatmentstreatment of the livercholesterolblood pressure and rheumatic treatments; veterinary preparations for treating digestive diseases and disordersgynecological diseases and disordersblood disorderscancercardiovascular diseasesvascular diseasesgastrointestinal diseasesgenitourinary diseasesimmunologic diseasesinfectious diseasesinflammatory diseasesmetabolic diseases and disordersneurological diseasescentral nervous systemmusculoskeletal systemrespiratory systemcirculatory systemviral diseasesglaucomadental and oral diseasesheadachesmigraineobesityhepatic treatmentscholesterolblood pressure and rheumatic treatmentsdietetic foods adapted for medical usebreadspastascrackerschipspackaged mealsnutritional food barscandydipssauces and food supplements in pillpowder capsulebeverage formeffervescent tablet and liquid form
Class 42
Chemicalbiological and pharmaceutical research services
Publications
History of USPTO decisions and trademark events.
48 publications found
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
08/06/2025
C71T
CANCELLED SECTION 71
12/06/2024
RNWL
INTERNATIONAL REGISTRATION RENEWED
09/26/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/21/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/30/2018
FIMP
FINAL DISPOSITION PROCESSED
08/30/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/22/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
05/22/2018
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/11/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/25/2018
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/25/2018
GPNX
NOTIFICATION PROCESSED BY IB
03/16/2018
GPNX
NOTIFICATION PROCESSED BY IB
03/09/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/06/2018
PUBO
PUBLISHED FOR OPPOSITION
03/06/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/14/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/14/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/14/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/30/2018
MNDA
NOTICE OF DIVIDED TRADEMARK APPLICATION MAILED
01/23/2018
DPCC
DIVISIONAL PROCESSING COMPLETE
01/19/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/16/2018
ALIE
ASSIGNED TO LIE
01/11/2018
EXPI
EX PARTE APPEAL-INSTITUTED
12/28/2017
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
12/28/2017
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
12/28/2017
DRRR
DIVISIONAL REQUEST RECEIVED
12/27/2017
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
12/27/2017
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
12/27/2017
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/27/2017
GNFR
FINAL REFUSAL E-MAILED
06/27/2017
CNFR
FINAL REFUSAL WRITTEN
06/27/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/06/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/05/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/05/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/05/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/05/2017
CHLD
CHANGE OF OWNER RECEIVED FROM IB
01/05/2017
RFNP
REFUSAL PROCESSED BY IB
12/30/2016
MAFR
APPLICATION FILING RECEIPT MAILED
12/06/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/05/2016
RFRR
REFUSAL PROCESSED BY MPU
12/05/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/03/2016
CNRT
NON-FINAL ACTION WRITTEN
12/02/2016
DOCK
ASSIGNED TO EXAMINER
12/01/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/01/2016
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
11/24/2016
Continuous trademark protection
Get notified about every new filing that threatens MABXIENCE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.